Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smart screening: approaches to efficient HTS.

M F Engels1, P Venkatarangan

  • 1Janssen Research Foundation, Tumhoutseweg 30, B-2340 Beerse, Belgium. MEngels2@janbe.jnj.com

Current Opinion in Drug Discovery & Development
|September 19, 2001
PubMed
Summary

High-throughput screening (HTS) is evolving. Hybrid strategies combining in silico and in vitro methods offer smarter, more cost-efficient drug discovery by improving screening scope and efficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.

Journal of medicinal chemistry·1999
Same author

Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats.

Neuropharmacology·1996
Same author

Urine protein excretion and swimming events.

Medicine and science in sports and exercise·1991
See all related articles

Area of Science:

  • Drug discovery and development
  • Computational chemistry
  • Pharmacology

Background:

  • The traditional 'brute-force' high-throughput screening (HTS) approach faces limitations due to an increasing number of drug targets and vast chemical libraries.
  • Pharmaceutical companies require enhanced screening scope and improved efficiency to remain competitive.
  • The limitations of conventional HTS necessitate the exploration of novel screening paradigms.

Purpose of the Study:

  • To review recent applications of hybrid screening strategies in drug discovery.
  • To discuss the impact of integrating in silico and in vitro screening methods.
  • To highlight the advantages of a combined screening approach for efficiency and cost-effectiveness.

Main Methods:

  • Integration of computational (in silico) and experimental (in vitro) screening techniques.
  • Development and application of hybrid screening workflows.
  • Analysis of case studies demonstrating the utility of integrated screening.

Main Results:

  • Hybrid screening strategies offer a more intelligent and cost-efficient approach to HTS.
  • The integration of in silico and in vitro methods enhances the scope and efficiency of screening experiments.
  • Novel screening paradigms are crucial for optimizing the drug discovery pipeline.

Conclusions:

  • Hybrid screening represents a significant advancement in drug discovery, optimizing resource utilization.
  • The synergistic combination of computational and experimental approaches leads to more effective lead identification.
  • Adoption of integrated screening strategies is vital for future pharmaceutical research and development.

Related Experiment Videos